Physician profile
Joseph Leonard Goldstein
NPI 1639640576
$5,513,848.52
in general payments reported to CMS, 2019-2025
1 company · $904K in 2025
The $904K reported for 2025 was more than what 99% of Clinical Genetics (M.D.) providers received nationally (typical 2025 total: $255).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $753K · 2020: $714K · 2021: $737K · 2022: $756K · 2023: $820K · 2024: $830K · 2025: $904K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2.1M · Travel and Lodging: $417K · Food and Beverage: $6,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,129,726.18 |
| Travel and Lodging | $417,398.64 |
| Food and Beverage | $6,478.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $5,513,848.52 | 2019-2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.